Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
May 14, 2013
Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity
John B Mumm, Martin Oft
Current Topics in Microbiology and Immunology
|
May 22, 2010
Subversion and coercion: the art of redirecting tumor immune surveillance
John B Mumm, Martin Oft
Oncoimmunology
|
December 25, 2012
Killing from within
John B Mumm, Jan Emmerich, Martin Oft
Oncoimmunology
|
December 25, 2012
Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8(+) T cells
Jan Emmerich, John B Mumm, Martin Oft
Cytokine
|
May 31, 2008
Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24
Suhendan Ekmekcioglu, John B Mumm, Malini Udtha, et al.
Receptors & Clinical Investigation
|
December 15, 2015
IL-10: Expanding the Immune Oncology Horizon
Ivan H Chan, Victoria Wu, Scott McCauley, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
January 24, 2007
Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes
John B Mumm, Suhendan Ekmekcioglu, Nancy J Poindexter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 27, 2005
mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer
Sunil Chada, Dora Bocangel, Rajagopal Ramesh, et al.
Cancer Research
|
May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
Jan Emmerich, John B Mumm, Ivan H Chan, et al.
Oncoimmunology
|
September 14, 2016
PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO
Ivan H Chan, Victoria Wu, Melissa Bilardello, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|
May 14, 2013
Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity
John B Mumm, Martin Oft
Current Topics in Microbiology and Immunology
|
May 22, 2010
Subversion and coercion: the art of redirecting tumor immune surveillance
John B Mumm, Martin Oft
Oncoimmunology
|
December 25, 2012
Killing from within
John B Mumm, Jan Emmerich, Martin Oft
Oncoimmunology
|
December 25, 2012
Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8(+) T cells
Jan Emmerich, John B Mumm, Martin Oft
Cytokine
|
May 31, 2008
Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24
Suhendan Ekmekcioglu, John B Mumm, Malini Udtha, et al.
Receptors & Clinical Investigation
|
December 15, 2015
IL-10: Expanding the Immune Oncology Horizon
Ivan H Chan, Victoria Wu, Scott McCauley, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
January 24, 2007
Soluble human MDA-7/IL-24: characterization of the molecular form(s) inhibiting tumor growth and stimulating monocytes
John B Mumm, Suhendan Ekmekcioglu, Nancy J Poindexter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 27, 2005
mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer
Sunil Chada, Dora Bocangel, Rajagopal Ramesh, et al.
Cancer Research
|
May 15, 2012
IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs
Jan Emmerich, John B Mumm, Ivan H Chan, et al.
Oncoimmunology
|
September 14, 2016
PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDO
Ivan H Chan, Victoria Wu, Melissa Bilardello, et al.
Page
of 3